Treace Medical Concepts, Inc.

NASDAQ:TMCI

Medical - Devices

Healthcare
$4.53 +1.87%

+$0.08 today

Market cap
$296.98M
Beta
1.41
P/E (TTM)
-4.3
EPS (TTM)
-$0.95
52W Low $1.17High $7.78

Volume 0.18M

Average 0.73M

TMCI Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

Treace Medical Concepts, Inc.NASDAQ: TMCI

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash turns negative

Q1 FY2026 net change in cash was -$1.16M, compared with $2.02M a year earlier. Trailing-twelve-month net change in cash was -$3.83M. Over 3 fiscal years it compounded at -80.5% a year.

Context

  • Net change in cash amounted to 0.3% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Net change in cash grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly net change in cash holds near -$1.16M or moves back toward the trailing-twelve-month quarterly average of -$957K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.16M-138.5% QoQ
Last fiscal yearDec 2025
-$642K-60.7% YoY
LTMMar 2026
-$3.83M-194.8% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-157.6%——
1 year-60.7%——
3-year CAGR-80.5%——
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(642K) USD
Year-over-year change
+60.7%

Net Change in Cash vs competitors

How TMCI compares with its peers on the latest reported figures

  • TMCI's LTM Mar 2026 net change in cash of $3.83M is the smallest of the 8 companies compared; the peer median is $10.43M.
  • Its year-over-year change of -194.8% is the 6th highest of 8, against a peer median of -37.7%.
  • Net change in cash amounts to 1.8% of revenue for TMCI, versus a peer median of 8.2%.
TMCI Competitors Peer median
Net Change in Cash for TMCI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LABStandard BioTools Inc.LTM Mar 2026$111.74M +182.9%—129.5%
CBLLCeriBell, Inc.LTM Mar 2026$108.11M -189.4%—113.7%
KIDSOrthoPediatrics Corp.LTM Mar 2026$21.18M -278.5%—8.7%
EOLSEvolus, Inc.LTM Mar 2026$18.1M -37.7%-28.9%6.0%
BVSBioventus Inc.LTM Mar 2026$13.04M +650.1%—2.3%
RXSTRxSight, Inc.LTM Mar 2026$10.43M +124.5%—8.2%
TOIThe Oncology Institute, Inc.LTM Mar 2026$9.46M -356.8%-45.8%1.7%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$3.83M -194.8%-80.5%1.8%
Peer median (excluding TMCI) $10.43M-37.7%-37.4%8.2%

Competitors are the stored peer set for TMCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(20.55M)(42.82M)(49.53M)(55.74M)(59M)
Depreciation & Amortization685K2.13M5.35M8.42M10.5M
Deferred Income Tax419K0000
Stock-Based Compensation3.41M8.11M17.35M30.6M33.82M
Change in Working Capital(1.33M)(5.81M)(9.74M)(25.43M)(8.58M)
Accounts Receivables(4.23M)(11.04M)(9.3M)(5.69M)(2.09M)
Inventory(3.09M)(8.77M)(9.85M)(10.01M)3.22M
Accounts Payables1.79M4.61M3.17M(1.31M)(3.8M)
Other Working Capital4.19M9.39M6.24M(8.42M)(5.92M)
Other Non-Cash Items176K7.73M1.99M4.99M7.29M
Operating Cash Flow(17.19M)(30.65M)(34.58M)(37.17M)(15.97M)
Capital Expenditures(2.71M)(14.84M)(11.46M)(11.59M)(13.52M)
Acquisitions (Net)061.68M(20M)00
Purchases of Investments0(63.41M)(169.87M)(71.58M)(40.57M)
Sales of Investments01.73M120.02M118.55M67.34M
Other Investing Activities0(61.68M)000
Investing Cash Flow(2.71M)(76.52M)(81.3M)35.38M13.25M
Debt Repayment(1.79M)19.61M002.43M
Common Stock Issued109.44M2.19M109.4M428K546K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(989K)(13K)(268K)(902K)
Financing Cash Flow107.65M20.81M109.38M160K2.08M
Effect of Forex Changes00000
Net Change in Cash87.75M(86.36M)(6.49M)(1.63M)(642K)
Free Cash Flow(19.9M)(45.49M)(46.03M)(48.76M)(29.49M)

Treace Medical Concepts, Inc.

NASDAQ:TMCI

Intrinsic Alpha fair value

Locked

Current Price

$4.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.